Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 142

Sort by

Sort Order Select

Journal Articles

The Ribomethylome Landscape of Hematopoietic System

Yanyan Wang, Christian Rohde, PhD, Fengbiao Zhou, PhD, Marco Hennrich, PhD, Laura Poisa-Beiro, PhD, Volker Eckstein, PhD, Caroline Pabst, MD, Anne-Claude Gavin, PhD, Anthony D Ho, MD, Carsten Müller-Tidow, MD

Blood (2020) 136 (Supplement 1): 41–42.

https://doi.org/10.1182/blood-2020-136522

Published: 2020

Journal Articles

Proteome Analyses and Single-Cell RNA Sequencing Reveal Age-Dependent Re-Wiring of Central Carbon Metabolism in Myeloid-Biased Subsets of Human Hematopoietic Stem Cells

Marco L Hennrich, PhD, Natalie Romanov, Patrick Horn, PhD, Samira Jaeger, PhD, Volker Eckstein, PhD, Laura Poisa-Beiro, PhD, Jacqueline Boultwood, PhD, Thomas Luft, MD PhD, Andrea Pellagatti, PhD, Peer Bork, PhD, Patrick Aloy, PhD, Anne-Claude Gavin, PhD, Anthony D. Ho, MD FRCPC

Blood (2018) 132 (Supplement 1): 873.

https://doi.org/10.1182/blood-2018-99-110787

Published: 2018

Journal Articles

Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase

Rüdiger Hehlmann, MD, Michael Lauseker, PhD, Susanne Saussele, MD, Markus Pfirrmann, Stefan W. Krause, MD, Hans-Jochem Kolb, MD, Andreas Neubauer, MD, Dieter K. Hossfeld, Christoph Nerl, MD, Alois Gratwohl, MD, Gabriela M. Baerlocher, Dominik Heim, MD, Tim Henrik Bruemmendorf, Alice Fabarius, PhD, Claudia Haferlach, MD, Brigitte Schlegelberger, MD PhD, Martin C. Müller, MD, Sabine Jeromin, PhD, Ulrike Proetel, PhD, Katharina Kohlbrenner, PhD, Astghik Voskanyan, PhD, Sébastien Rinaldetti, Wolfgang Seifarth, PhD, Birgit Spiess, Leopold Balleisen, MD, Maria E Goebeler, MD, Mathias Hänel, MD, Anthony D. Ho, MD, J Dengler, C Falge, Lothar Kanz, MD, Claus-Henning Köhne, MD, PhD, Andreas Burchert, MD, Michael Kneba, MD PhD, Frank Stegelmann, MD, C Köhne, Hans-Walter Lindemann, C Waller, Michael Pfreundschuh, MD, Karsten Spiekermann, Wolfgang E Berdel, MD, L Müller, Matthias Edinger, MD, Jiri Mayer, Prof, MD SCs, Dietrich W Beelen, MD PhD, Martin Bentz, MD, Hartmut Link, MDPhD, Bernd Hertenstein, MD, R Fuchs, Martin Wernli, MD, F Schlegel, Rudolph Schlag, M de Wit, Lorenz Trümper, MD, H Hebarth, M Hahn, Jörg Thomalla, MD, Christof Scheid, MD, Philippe Schafhausen, MD, Walter Verbeek, MD, Michael J. Eckart, MD, Winfried Gassmann, MD PhD, Antonio Pezzutto, MD, Michael Schenk, Peter Brossart, MD, Thomas Geer, MD, Stephan Bildat, E Schäfer, Andreas Hochhaus, MD, Joerg Hasford

Blood (2017) 130 (Supplement 1): 897.

https://doi.org/10.1182/blood.V130.Suppl_1.897.897

Published: 2017

Journal Articles

Proteomics Analysis of Cellular Network in Human Bone Marrow Reveals Lineage Skewing Towards Megakaryocytes and Decrease in Lymphoid Development upon Aging

Anthony D. Ho, MD, Patrick Horn, PhD, Marco Hennrich, PhD, Samira Jaeger, PhD, Natalie Romanov, Ximing Ding, Peer Bork, PhD, Patrick Aloy, PhD, Anne-Claude Gavin, PhD

Blood (2016) 128 (22): 2658.

https://doi.org/10.1182/blood.V128.22.2658.2658

Published: 2016

Journal Articles

Clinical Impact of KMT2C and SPRY4 Expression Levels in Intensively Treated Younger Adult Acute Myeloid Leukemia Patients

Sabine Kayser, MD, Maximilian Feszler, Julia Krzykalla, Matthias Schick, Thomas Hielscher, Axel Benner, Michael Kramer, Felicitas Thol, MD, Uwe Platzbecker, MD, Anthony D. Ho, MD, Gerhard Ehninger, MD, Michael Heuser, MD, Christian Thiede, MD, Christoph Röllig, MD, Alwin Krämer, MD

Blood (2016) 128 (22): 1663.

https://doi.org/10.1182/blood.V128.22.1663.1663

Published: 2016

Journal Articles

Parainfluenza Virus Infections in Patients with Hematologic Malignancies or Following Stem Cell Transplantation: Analysis of Clinical Characteristics, Nosocomial Transmission and Prolonged Viral Shedding

Nicola Lehners, MD, Joe Puthenparambil, MD, Martin Schiller, MD, Anthony D. Ho, MD, Paul Schnitzler, MD, Gerlinde Egerer, MD

Blood (2016) 128 (22): 3401.

https://doi.org/10.1182/blood.V128.22.3401.3401

Published: 2016

Journal Articles

Evaluation of Stem Cell Mobilization in Patients with Multiple Myeloma after Lenalidomide-Based Induction Chemotherapy within the GMMG-HD6 Trial

Blood (2016) 128 (22): 3373.

https://doi.org/10.1182/blood.V128.22.3373.3373

Published: 2016

Journal Articles

Marked Impact of Different Cytokines on Phenotype and Cytotoxic Activity of CD19-Specific CAR T Cells

Jean-Marc Hoffmann, Lei Wang, Angela Hückelhoven, PhD, Anita Schmitt, MD, Ulrike Gern, Leopold Sellner, MD, Christian Kleist, PhD, Jessica Wenthe, Patrick Wuchter, MD, Maria-Luisa Schubert, MD, Hyeon Joo Yoo, Ming Ni, Susanne Hofmann, MD, Peter Dreger, MD, Anthony D. Ho, MD, Angelica Loskog, PhD, Michael Schmitt, MD

Blood (2016) 128 (22): 3509.

https://doi.org/10.1182/blood.V128.22.3509.3509

Published: 2016

Journal Articles

Asymptomatic Multiple Myeloma - Background of Progression, Evolution, and Prognosis

Blood (2016) 128 (22): 235.

https://doi.org/10.1182/blood.V128.22.235.235

Published: 2016

Journal Articles

Peptide Vaccination Against Cytomegalovirus (CMV) Elicits Immunological and Clinical Responses after Allogeneic Stem Cell Transplantation Even from a CMV Seronegative Donor

Blood (2016) 128 (22): 2519.

https://doi.org/10.1182/blood.V128.22.2519.2519

Published: 2016

Journal Articles

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

Thomas Luft, MD PhD, Axel Benner, Sonata Jodele, MD, Christopher E. Dandoy, MD, Rainer F. Storb, MD, Ted A. Gooley, PhD, Brenda M. Sandmaier, MD, Aleksandar Radujkovic, MD, Anthony D. Ho, MD, Peter Dreger, MD, Olaf Penack, MD

Blood (2016) 128 (22): 519.

https://doi.org/10.1182/blood.V128.22.519.519

Published: 2016

Journal Articles

Identification of Novel Immune-Checkpoint Molecules on Multiple Myeloma Cells Using a High-Throughput Discovery Platform

Valentina Volpin, Till Michels, Antonio Sorrentino, Dirk Hose, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Philipp Beckhove, Mathias Witzens-Harig, MD

Blood (2016) 128 (22): 380.

https://doi.org/10.1182/blood.V128.22.380.380

Published: 2016

Journal Articles

A Distributed International Patient Data Registry for Hairy Cell Leukemia

Leslie A. Andritsos, MD, Michael R. Grever, MD, Mirela Anghelina, MD, Claire E Dearden, MD FRCP, FRCPath, Monica Else, MA, MSc, James S. Blachly, MD, Omkar Lele, MS, MBA, Farhad Ravandi, MD, Clive S Zent, MD, James B. Johnston, MD FRCP, Versha Banerji, MD FRCP, Francesco Forconi, MD DM, PhD FRCPath, Anthony D. Ho, MD, Thorsten Zenz, Sascha Dietrich, Judit Demeter, MD PhD, Jacqueline C. Barrientos, MD, Jan A. Burger, MD PhD, Timothy G. Call, MD, Nicholas Chiorazzi, MD, Daniel J. DeAngelo, MD PhD, Julio Delgado, MD, Andrei Fagarasanu, MD PhD, Brunangelo Falini, Alessandro Gozzetti, MD, Jeffrey Jones, MD MPH, Gunnar Juliusson, MD, Eric H. Kraut, MD, Robert J. Kreitman, MD, Loree Larratt, MD, Francesco Lauria, MD, Gerard Lozanski, MD, Emili Montserrat, MD, Sameer A. Parikh, MD, Jae H. Park, MD, Aaron Polliack, MD, Graeme R. Quest, MD MSc, Kanti R. Rai, MD, Tadeusz Robak, MD PhD, Alan Saven, MD, Tamar Tadmor, MD, Martin S. Tallman, MD, Constantine S. Tam, MBBS, Enrico Tiacci, MD, Xavier Troussard, MD PhD, Omar Abdel-Wahab, MD, Pier Luigi Zinzani, MD, PhD, Christopher Heckler, BS, MBA, Philip R.O. Payne, PhD

Blood (2016) 128 (22): 5986.

https://doi.org/10.1182/blood.V128.22.5986.5986

Published: 2016

Journal Articles

Pan-Mutant-IDH1 Inhibitor Bay-1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia In Vivo

Blood (2016) 128 (22): 745.

https://doi.org/10.1182/blood.V128.22.745.745

Published: 2016

Journal Articles

Marker Chromosomes Can Arise from Chromothripsis and Predict Adverse Prognosis in Acute Myeloid Leukemia

Tilmann Bochtler, MD, Martin Granzow, PhD, Friedrich Stölzel, MD, Christina Kunz, PhD, Brigitte Mohr, PhD, Mutlu Kartal-Kaess, MD, Johannes W.G. Janssen, PhD, Christoph E. Heilig, MD, Michael Kramer, MSc, Christian Thiede, MD, Axel Benner, Martin Bornhäuser, MD, Gerhard Ehninger, MD, Anthony D. Ho, MD, Anna Jauch, PhD, Alwin Krämer, MD

Blood (2016) 128 (22): 2869.

https://doi.org/10.1182/blood.V128.22.2869.2869

Published: 2016

Journal Articles

Low Pre-Transplant Testosterone Levels in Male Patients Are Associated with Endothelial Vulnerability and Non-Relapse Mortality after Allogeneic Stem Cell Transplantation

Aleksandar Radujkovic, MD, Dietrich W. Beelen, Prof. Dr. MD, Christian Kasperk, Anthony D. Ho, MD, Peter Dreger, MD, Thomas Luft, MD PhD

Blood (2016) 128 (22): 4587.

https://doi.org/10.1182/blood.V128.22.4587.4587

Published: 2016

Journal Articles

Efficacy and Tolerability of the Histone-Deacetylase Inhibitor Panobinostat in Clinical Practice: a Single Center Experience

Marc-A. Baertsch, MD, Jens Hillengass, MD, Stefan Schönland, MD, Ute Hegenbart, MD, Anthony D. Ho, MD, Hartmut Goldschmidt, MD, Marc S. Raab, MD

Blood (2016) 128 (22): 5686.

https://doi.org/10.1182/blood.V128.22.5686.5686

Published: 2016

Journal Articles

Addition of Rituximab to CHOP-like Chemotherapy Improves Survival in Patients with Primary Mediastinal B-Cell Lymphoma Independent of IPI Risk Category

Katharina Lisenko, MD, Gerrit Dingeldein, Martin Cremer, MD, Mark Kriegsmann, Anthony D. Ho, MD, Michael Rieger, MD, Mathias Witzens-Harig, MD

Blood (2016) 128 (22): 4223.

https://doi.org/10.1182/blood.V128.22.4223.4223

Published: 2016

Journal Articles

Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Report of the Prospective, Multicenter Phase II STORM Trial

Mathias Witzens-Harig, MD, Andreas Viardot, Ulrich Keller, Christian Buske, Anne Crombé, Elisabeth Hoenig, Johannes Atta, Johann Schmier, MD, Julia Meissner, MD, Anthony D. Ho, MD, Paul LaRosee, MD, Reinhard Marks, MD, Martin Dreyling, MD PhD, Georg Hess, MD

Blood (2016) 128 (22): 3028.

https://doi.org/10.1182/blood.V128.22.3028.3028

Published: 2016

Journal Articles

Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Results of the Part I Cohort of the STORM Trial

Mathias Witzens-Harig, MD, Ulrich Keller, Andreas Viardot, MD, Christian Buske, MD, Anne Crombé, Elisabeth Hoenig, Julia Meissner, MD, Anthony D Ho, MD, Reinhard Marks, Martin H. Dreyling, MD PhD, Georg Hess, MD

Blood (2015) 126 (23): 2727.

https://doi.org/10.1182/blood.V126.23.2727.2727

Published: 2015

NARROW

The Ribomethylome Landscape of Hematopoietic System

Proteome Analyses and Single-Cell RNA Sequencing Reveal Age-Dependent Re-Wiring of Central Carbon Metabolism in Myeloid-Biased Subsets of Human Hematopoietic Stem Cells

Final Evaluation of Randomized CML-Study IV: 10-Year Survival and Evolution of Terminal Phase

Proteomics Analysis of Cellular Network in Human Bone Marrow Reveals Lineage Skewing Towards Megakaryocytes and Decrease in Lymphoid Development upon Aging

Clinical Impact of KMT2C and SPRY4 Expression Levels in Intensively Treated Younger Adult Acute Myeloid Leukemia Patients

Parainfluenza Virus Infections in Patients with Hematologic Malignancies or Following Stem Cell Transplantation: Analysis of Clinical Characteristics, Nosocomial Transmission and Prolonged Viral Shedding

Evaluation of Stem Cell Mobilization in Patients with Multiple Myeloma after Lenalidomide-Based Induction Chemotherapy within the GMMG-HD6 Trial

Marked Impact of Different Cytokines on Phenotype and Cytotoxic Activity of CD19-Specific CAR T Cells

Asymptomatic Multiple Myeloma - Background of Progression, Evolution, and Prognosis

Peptide Vaccination Against Cytomegalovirus (CMV) Elicits Immunological and Clinical Responses after Allogeneic Stem Cell Transplantation Even from a CMV Seronegative Donor

It Is Easix to Predict Non-Relapse Mortality (NRM) of Allogeneic Stem Cell Transplantation (alloSCT)

Identification of Novel Immune-Checkpoint Molecules on Multiple Myeloma Cells Using a High-Throughput Discovery Platform

A Distributed International Patient Data Registry for Hairy Cell Leukemia

Pan-Mutant-IDH1 Inhibitor Bay-1436032 Is Highly Effective Against Human IDH1 Mutant Acute Myeloid Leukemia In Vivo

Marker Chromosomes Can Arise from Chromothripsis and Predict Adverse Prognosis in Acute Myeloid Leukemia

Low Pre-Transplant Testosterone Levels in Male Patients Are Associated with Endothelial Vulnerability and Non-Relapse Mortality after Allogeneic Stem Cell Transplantation

Efficacy and Tolerability of the Histone-Deacetylase Inhibitor Panobinostat in Clinical Practice: a Single Center Experience

Addition of Rituximab to CHOP-like Chemotherapy Improves Survival in Patients with Primary Mediastinal B-Cell Lymphoma Independent of IPI Risk Category

Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Report of the Prospective, Multicenter Phase II STORM Trial

Safety and Clinical Activity of Temsirolimus in Combination with Rituximab and DHAP in Patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma - Results of the Part I Cohort of the STORM Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only